Laboratorios Farmaceuticos Rovi, S.A. (VIE:ROVI)
60.05
-0.10 (-0.17%)
Last updated: Dec 5, 2025, 11:00 AM CET
VIE:ROVI Revenue
Laboratorios Farmaceuticos Rovi had revenue of 210.47M EUR in the quarter ending September 30, 2025, a decrease of -10.54%. This brings the company's revenue in the last twelve months to 724.20M, down -9.39% year-over-year. In the year 2024, Laboratorios Farmaceuticos Rovi had annual revenue of 763.75M, down -7.93%.
Revenue (ttm)
724.20M
Revenue Growth
-9.39%
P/S Ratio
4.24
Revenue / Employee
329.63K
Employees
2,197
Market Cap
3.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 763.75M | -65.76M | -7.93% |
| Dec 31, 2023 | 829.51M | 11.81M | 1.44% |
| Dec 31, 2022 | 817.70M | 169.02M | 26.06% |
| Dec 31, 2021 | 648.68M | 228.72M | 54.46% |
| Dec 31, 2020 | 419.96M | 38.65M | 10.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| OMV Aktiengesellschaft | 31.89B |
| Strabag SE | 17.92B |
| Voestalpine AG | 15.29B |
| Vienna Insurance Group AG | 13.13B |
| Erste Group Bank AG | 10.96B |
| Raiffeisen Bank International AG | 8.90B |
| VERBUND AG | 8.30B |
| Andritz AG | 7.84B |